A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease

Clinical trial NCT04992065 · COMPLETED

Trial details

NCT number: NCT04992065
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atherosclerotic Cardiovascular Disease

Start date: 2021-08-03
Primary completion: 2022-04-26
Enrollment: 267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.